生物技术公司Kezar Life Sciences Inc.(简称Kezar)宣布,其与Enodia Therapeutics达成的合作协议中,Kezar将获得100万美元的预付款。此外,根据后续研发和商业化进展,Kezar还有资格获得最高达1.27亿美元的里程碑付款。
此次合作凸显了双方在创新疗法开发领域的战略布局。协议条款的披露,为市场提供了对Kezar未来潜在收入流的清晰展望。值得注意的是,原公告中遗漏了"Kezar"一词,现已予以更正。
生物技术公司Kezar Life Sciences Inc.(简称Kezar)宣布,其与Enodia Therapeutics达成的合作协议中,Kezar将获得100万美元的预付款。此外,根据后续研发和商业化进展,Kezar还有资格获得最高达1.27亿美元的里程碑付款。
此次合作凸显了双方在创新疗法开发领域的战略布局。协议条款的披露,为市场提供了对Kezar未来潜在收入流的清晰展望。值得注意的是,原公告中遗漏了"Kezar"一词,现已予以更正。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.